Ian Michael Estepan - 26 Feb 2026 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
Chief Operating Officer
Signature
/s/ Cristin L. Rothfuss, as Attorney-in-Fact for Ian Michael Estepan
Issuer symbol
SRPT
Transactions as of
26 Feb 2026
Net transactions value
+$102,140
Form type
4
Filing time
02 Mar 2026, 08:00:04 UTC
Previous filing
27 Feb 2026
Next filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Estepan Ian Michael Chief Operating Officer 215 FIRST STREET, SUITE 415, CAMBRIDGE /s/ Cristin L. Rothfuss, as Attorney-in-Fact for Ian Michael Estepan 02 Mar 2026 0001836254

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Options Exercise $28,366 +2,069 +1.1% $13.71 195,369 26 Feb 2026 Direct F1
transaction SRPT Common Stock Options Exercise $73,774 +5,381 +2.8% $13.71 200,750 26 Feb 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRPT Stock Option (right to buy) Options Exercise $0 -2,069 -100% $0.000000 0 26 Feb 2026 Common Stock 2,069 $13.71 Direct
transaction SRPT Stock Option (right to buy) Options Exercise $0 -5,381 -100% $0.000000 0 26 Feb 2026 Common Stock 5,381 $13.71 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares held by the Reporting Person after the exercise of a stock option.